Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway

Neurology
Carol F LippaD Pollen

Abstract

Whether all etiologic forms of Alzheimer's disease (AD) share a final common pathway is a major issue. We determined the severity and regional distribution of neuronal loss, amyloid plaques, neuritic plaques (NPs), and neurofibrillary tangles (NFTs), and calculated the ratio of neuronal loss to NPs and NFTs in brains of 19 familial AD (FAD) patients with linkage to chromosome 14, six AD patients with mutations of chromosome 21 (codon 717 of the beta-amyloid percursor protein gene), and 11 sporadic AD (SAD) patients. There was no difference in the pattern of distribution of the various pathologic features or in the ratio of neuronal loss to NPs or NFTs in any AD group. However, FAD groups could be distinguished from SAD by the greater severity and the lack of influence of apolipoprotein E genotype on pathology. These differences may reflect differences in age at onset rather than different etiopathologic mechanisms. The similarity of pathologic findings in the different AD groups provides evidence for a final common pathophysiologic pathway in AD.

Citations

Apr 1, 1997·Annals of Neurology·V Askanas
Nov 19, 2008·Acta Neuropathologica·Adele WoodhouseJames C Vickers
Mar 24, 2009·Acta Neuropathologica·Claire ShepherdGlenda Margaret Halliday
May 24, 2012·Acta Neuropathologica·Gerard D Schellenberg, Thomas J Montine
May 17, 2005·Neurobiology of Aging·Gillian C GregoryGlenda M Halliday
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Randall J Bateman, William E Klunk
Apr 15, 1997·Journal of the Neurological Sciences·C F LippaT W Smith
Jun 6, 2000·Advanced Drug Delivery Reviews·W A Marasco, Dana Jones S
Dec 22, 2000·Neurobiology of Aging·J W HussemanI Vincent
Sep 10, 2002·Alzheimer Disease and Associated Disorders·Guilian XuDavid R Borchelt
Jun 8, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William E KlunkSteven T DeKosky
Jun 22, 2007·Acta Neuropathologica·Ellen BoelenHarry W M Steinbusch
Nov 4, 2000·Expert Opinion on Investigational Drugs·M HüllB L Fiebich
Feb 7, 2007·Journal of Neuropathology and Experimental Neurology·Keith A JosephsDennis W Dickson
Oct 3, 2009·Neurobiology of Aging·Michael SchöllAgneta Nordberg
Jul 19, 2012·Journal of Neuropathology and Experimental Neurology·Alberto Serrano-PozoBradley T Hyman
Jun 16, 2009·Neurochemistry International·E Hellström-LindahlA Marutle
Aug 18, 2009·Neuropathology and Applied Neurobiology·G SimicP R Hof
Apr 1, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Gianluigi ForloniClaudia Balducci
Nov 3, 1998·Lancet·C F LippaP St George-Hyslop
Dec 24, 2004·Biochimica Et Biophysica Acta·Jormay Lim, Kun Ping Lu
Aug 29, 2014·Frontiers in Aging Neuroscience·Robert A Marr, Daniel M Hafez
Nov 1, 2016·Journal of Neurochemistry·Eric Karran, Bart De Strooper
Apr 8, 2015·PloS One·Yi SuTammie L S Benzinger
Jan 13, 2017·Journal of the International Neuropsychological Society : JINS·Ove AlmkvistCaroline Graff
May 21, 2013·American Journal of Alzheimer's Disease and Other Dementias·Alka KaushalKiran Dip Gill
Apr 17, 2001·American Journal of Alzheimer's Disease and Other Dementias·L E Nee, C F Lippa
Jun 19, 2003·American Journal of Alzheimer's Disease and Other Dementias·Juan Carlos Arango LasprillaFrancisco Lopera
Jun 13, 2000·Nature·C RussoJ K Teller
Nov 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Tammie L S BenzingerJohn C Morris
Mar 2, 2018·Environmental Epigenetics·Amy S YokoyamaValentina Medici

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.